Snowden Capital Advisors LLC Spring Works Therapeutics, Inc. Transaction History
Snowden Capital Advisors LLC
- $3.12 Billion
- Q4 2024
A detailed history of Snowden Capital Advisors LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 11,454 shares of SWTX stock, worth $686,438. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,454
Previous 11,356
0.86%
Holding current value
$686,438
Previous $363,000
13.77%
% of portfolio
0.01%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$429 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$337 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$207 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$196 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$180 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.74B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...